Skip to main content
. 2017 Jan 26;2017:8983763. doi: 10.1155/2017/8983763

Figure 2.

Figure 2

Comparison of TFPI-1 levels in NSCLC patients with different clinical conditions. TFPI-1: tissue factor pathway inhibitor-1. DVT: deep venous thrombosis. P < 0.01: compared with non-DVT and nonmetastasis, respectively.